Medtronic (MDT) stock price, revenue, and financials

Medtronic market cap is $143.4 b, and annual revenue was $30.12 b in FY 2021

$143.4 B

MDT Mkt cap, 27-Apr-2022

$7.8 B

Medtronic Revenue Q3, 2022
Medtronic Gross profit (Q3, 2022)6 B
Medtronic Net income (Q3, 2022)1.5 B
Medtronic EBITDA (Q3, 2022)2.7 B
Medtronic EBIT (Q3, 2022)1.5 B
Medtronic Cash, 28-Jan-20223.5 B
Medtronic EV165 B
Get notified regarding key financial metrics and revenue changes at MedtronicLearn more
Banner background

Medtronic Revenue Breakdown

Embed Graph

Medtronic revenue breakdown by business segment: 8.0% from DIABETES GROUP, 29.0% from MEDICAL SURGICAL, 27.2% from NEUROSCIENCE and 35.8% from CARDIOVASCULAR

Medtronic Income Statement

Annual

USDFY, 2018FY, 2019FY, 2020FY, 2021

Revenue

30.0b30.6b28.9b30.1b

Cost of goods sold

(8.2b)(8.3b)(8.5b)(9.6b)

Gross profit

22.4b22.3b20.4b20.6b

R&D expense

(2.3b)(2.3b)(2.3b)(2.5b)

Operating expense total

(12.8b)(13.7b)(13.1b)(13.5b)

Depreciation and amortization

(2.7b)(2.7b)(2.7b)(2.7b)

EBITDA

9.7b8.6b7.3b7.0b

EBIT

6.9b6.2b4.7b4.5b

Interest expense

(1.1b)(1.4b)(1.1b)(925.0m)

Interest income

397.0m300.0m192.0m

Pre tax profit

5.7b5.2b4.1b3.9b

Income tax expense

(2.6b)(547.0m)751.0m(265.0m)

Net Income

3.1b4.7b4.8b3.6b

Quarterly

USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021Q1, 2022Q2, 2022Q3, 2022

Revenue

7.4b7.5b7.5b7.5b7.7b7.7b6.5b7.6b7.8b8.0b7.8b7.8b

Cost of goods sold

(1.5b)(2.4b)(1.1b)(2.1b)(2.2b)(2.2b)(2.3b)(2.5b)(2.4b)(2.4b)(2.3b)(1.8b)

Gross profit

5.8b5.0b6.4b5.4b5.5b5.5b4.3b5.1b5.4b5.6b5.6b6.0b

R&D expense

(585.0m)(590.0m)(561.0m)(587.0m)(603.0m)(573.0m)(621.0m)(639.0m)(601.0m)(750.0m)(676.0m)(668.0m)

Operating expense total

(3.3b)(3.6b)(3.3b)(3.2b)(3.5b)(3.2b)(3.1b)(3.5b)(3.4b)(4.1b)(3.3b)(3.3b)

Depreciation and amortization

(1.1b)(205.0m)(675.0m)(657.0m)(671.0m)(663.0m)(669.0m)(671.0m)(678.0m)(671.0m)(676.0m)(1.1b)

EBITDA

2.5b1.4b3.1b2.1b2.0b2.3b1.2b1.6b1.9b1.6b2.3b2.7b

EBIT

1.3b1.5b2.3b1.6b1.4b1.8b655.0m888.0m1.3b914.0m1.6b1.5b

Interest expense

(242.0m)(241.0m)(243.0m)(609.0m)(165.0m)(156.0m)(171.0m)(470.0m)(142.0m)(137.0m)(136.0m)(137.0m)

Interest income

202.0m98.0m46.0m43.0m46.0m45.0m

Pre tax profit

1.2b1.4b2.3b977.0m1.3b1.6b584.0m525.0m1.2b833.0m1.5b1.6b

Income tax expense

(103.0m)(235.0m)(99.0m)(100.0m)77.0m(294.0m)(93.0m)(31.0m)59.0m(64.0m)(176.0m)(106.0m)

Net Income

1.1b1.1b2.2b877.0m1.4b1.3b491.0m494.0m1.3b769.0m1.3b1.5b

Medtronic Balance Sheet

Annual

USDFY, 2018FY, 2019FY, 2020FY, 2021

Cash

3.7b4.4b4.1b3.6b

Accounts Receivable

6.0b6.2b4.6b5.5b

Inventories

3.6b3.8b4.2b4.3b

Current Assets

23.0b22.0b22.0b22.5b

PP&E

4.6b4.7b4.8b5.2b

Goodwill

39.5b40.0b39.8b42.0b

Total Assets

91.4b89.7b90.7b93.1b

Accounts Payable

1.6b2.0b2.0b2.1b

Short-term debt

2.1b838.0m2.8b11.0m

Current Liabilities

10.1b8.5b10.4b8.5b

Long-term debt

23.7b24.5b22.0b26.4b

Non-Current Liabilities

30.5b31.0b29.5b33.0b

Total Debt

25.8b25.3b24.8b26.4b

Total Liabilities

40.6b39.5b39.8b41.5b

Additional Paid-in Capital

28.1b26.5b26.2b26.3b

Retained Earnings

24.4b26.3b28.1b28.6b

Total Equity

50.8b50.2b50.9b51.6b

Quarterly

USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021Q1, 2022Q2, 2022Q3, 2022

Cash

4.4b3.9b3.7b5.1b4.0b3.7b6.5b6.4b5.1b3.0b2.9b3.5b

Accounts Receivable

5.7b5.7b5.9b5.9b6.1b6.2b4.9b5.3b5.2b5.4b5.5b5.4b

Inventories

3.7b3.8b3.9b3.9b4.0b4.1b4.6b4.5b4.5b4.3b4.3b4.5b

Current Assets

22.5b21.7b20.9b22.7b22.7b24.0b24.5b26.0b26.3b22.4b22.7b23.3b

PP&E

4.5b4.5b4.6b4.7b4.8b4.8b4.9b4.9b5.0b5.2b5.2b5.3b

Goodwill

39.0b38.6b40.0b40.1b40.0b40.1b40.7b41.2b42.1b41.7b41.6b41.3b

Total Assets

89.7b88.2b88.7b91.3b91.1b92.8b93.9b95.9b97.3b91.8b91.8b91.8b

Accounts Payable

1.8b1.7b1.7b1.9b2.0b1.9b1.7b1.9b1.8b1.9b1.9b2.0b

Short-term debt

1.5b1.3b1.4b1.5b875.0m844.0m5.8b4.0b3.8b6.0m16.0m865.0m

Current Liabilities

9.1b8.5b8.9b8.5b8.2b8.7b13.1b12.1b12.5b7.8b7.8b8.9b

Long-term debt

23.7b23.7b23.7b24.8b24.8b24.7b22.9b26.0b26.5b26.0b25.6b24.3b

Non-Current Liabilities

30.3b30.0b29.9b32.3b32.2b32.1b30.4b33.5b33.8b32.4b31.8b30.2b

Total Debt

25.2b25.0b25.0b26.3b25.6b25.6b28.7b30.0b30.3b26.0b25.6b25.2b

Total Liabilities

39.4b38.4b38.8b40.8b40.3b40.9b43.5b45.6b46.3b40.1b39.6b39.1b

Additional Paid-in Capital

27.8b27.0b26.5b26.5b26.2b26.1b26.3b26.5b26.7b26.2b26.1b25.8b

Retained Earnings

24.7b25.2b25.8b26.4b27.0b28.2b27.8b27.5b28.0b28.5b29.0b29.6b

Total Equity

50.3b49.7b49.9b50.5b50.7b52.0b50.4b50.3b50.9b51.7b52.2b52.7b

Medtronic Cash Flow

Annual

USDFY, 2018FY, 2019FY, 2020FY, 2021

Net Income

3.1b4.7b4.8b3.6b

Depreciation and Amortization

2.6b2.7b2.7b2.7b

Accounts Receivable

(275.0m)(581.0m)1.3b(761.0m)

Inventories

(192.0m)(274.0m)(577.0m)78.0m

Accounts Payable

65.0m399.0m(44.0m)531.0m

Cash From Operating Activities

4.7b7.0b7.2b6.2b

Cash From Investing Activities

5.9b(774.0m)(3.2b)(2.9b)

Short-term Borrowings

(293.0m)(713.0m)(17.0m)(64.0m)

Long-term Borrowings

(7.3b)(154.0m)(542.0m)(195.0m)

Dividends Paid

(2.5b)(2.7b)(2.9b)(3.1b)

Cash From Financing Activities

(12.0b)(5.4b)(4.2b)(4.1b)

Net Change in Cash

(1.3b)724.0m(253.0m)(547.0m)

Quarterly

USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021Q1, 2022Q2, 2022Q3, 2022

Net Income

1.1b2.2b3.5b877.0m2.2b4.2b491.0m985.0m2.3b769.0m2.1b3.6b

Depreciation and Amortization

666.0m1.3b2.0b657.0m1.3b2.0b669.0m1.3b2.0b671.0m1.3b2.0b

Accounts Receivable

138.0m(37.0m)(140.0m)319.0m39.0m(119.0m)(142.0m)(669.0m)(450.0m)(40.0m)(171.0m)(212.0m)

Inventories

(180.0m)(312.0m)(367.0m)(122.0m)(267.0m)(346.0m)(235.0m)(145.0m)(75.0m)(75.0m)(156.0m)(359.0m)

Accounts Payable

85.0m24.0m211.0m(629.0m)(294.0m)103.0m(541.0m)108.0m529.0m(416.0m)(446.0m)6.0m

Cash From Operating Activities

1.7b2.9b4.9b1.5b3.4b5.8b278.0m2.1b4.5b1.3b3.1b5.3b

Cash From Investing Activities

643.0m764.0m(245.0m)(551.0m)(1.8b)(3.6b)8.0m(2.0b)(4.8b)(784.0m)(1.5b)(1.9b)

Short-term Borrowings

(700.0m)88.0m17.0m2.8b2.7b2.5b

Long-term Borrowings

(517.0m)(16.0m)(29.0m)532.0m(26.0m)(38.0m)(11.0m)836.0m721.0m(1.0m)(1.0m)(1.0m)

Dividends Paid

(677.0m)(1.4b)(2.0b)(724.0m)(1.4b)(2.2b)(778.0m)(1.6b)(2.3b)(846.0m)(1.7b)(2.5b)

Cash From Financing Activities

(1.6b)(3.3b)(4.6b)(274.0m)(2.0b)(2.9b)2.0b2.0b993.0m(1.1b)(2.2b)(3.4b)

Net Change in Cash

711.0m242.0m34.0m687.0m(431.0m)(684.0m)2.4b2.3b937.0m(589.0m)(693.0m)(114.0m)

Medtronic Ratios

USDFY, 2018

Revenue/Employee

346.8k

Medtronic Operating Metrics

FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019Jun, 2020FY, 2020FY, 2021

Countries

160160160150150150150

Floor Space, square feet

9 m9.4 m9.6 m

Manufacturing Facilities

8089

Patents and Patent Applications

49 k

Patients Served per Year

72 m

Sales Offices

345224189180

Trademarks

836

Medtronic Human Capital

FY, 2021FY, 2020FY, 2019FY, 2018FY, 2017FY, 2016FY, 2015FY, 2014
Male, percent25%25%25%25%25.5%51%52%51%
Female, percent25%25%25%25%24.5%49%48%49%
Female (Management), percent19.5%19%19%18.5%17%
Male (Management), percent30.5%31%31%31.5%33%

Medtronic Employee Rating

4.17169 votes
Culture & Values
3.9
Work/Life Balance
3.6
Senior Management
3.4
Salary & Benefits
3.9
Career Opportunities
3.5
Source